University of British Columbia, Vancouver, British Columbia, Canada.
Department of Laboratory Medicine, Island Health, Victoria, British Columbia, Canada.
J Cutan Pathol. 2021 May;48(5):617-624. doi: 10.1111/cup.13956. Epub 2021 Jan 23.
Chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) is associated with an increased risk of a second malignancy.
We conducted a retrospective clinicopathologic review of 12 patients with CLL/SLL who developed a second lymphoma in the skin. Demographic data, clinical information, and histopathology from 31 biopsies were recorded. Cases of secondary cutaneous involvement by CLL/SLL (leukemia cutis) and non-primary cutaneous lymphomas were excluded.
A wide variety of primary cutaneous lymphomas was identified, including classic mycosis fungoides (3), cutaneous marginal zone lymphoma (2), primary cutaneous peripheral T-cell lymphoma unspecified (2), folliculotropic mycosis fungoides (1), Sézary syndrome (1), cutaneous gamma-delta T-cell lymphoma (1), cutaneous CD8+ aggressive epidermotropic cytotoxic T-cell lymphoma (1), and cutaneous anaplastic large cell lymphoma (1). A male predominance was observed, and the average age was 74.1 years. In all patients, CLL/SLL predated the development of the second lymphoma, which was aggressive in the majority of cases (58%). Aggressive cytotoxic T-cell lymphomas, generally rare neoplasms, were relatively common (30%).
CLL/SLL patients may develop a second lymphoma in the skin, which may be aggressive. Atypical cutaneous lymphoid infiltrates in this patient population should not be assumed to represent secondary CLL/SLL involvement and require thorough immunohistochemical analysis.
慢性淋巴细胞白血病/小淋巴细胞淋巴瘤(CLL/SLL)与第二种恶性肿瘤的风险增加有关。
我们对 12 例在皮肤中发生第二种淋巴瘤的 CLL/SLL 患者进行了回顾性临床病理研究。记录了 31 次活检的人口统计学数据、临床信息和组织病理学。排除了 CLL/SLL(白血病皮肤)和非原发性皮肤淋巴瘤的继发性皮肤受累病例。
确定了多种原发性皮肤淋巴瘤,包括经典蕈样真菌病(3 例)、皮肤边缘区淋巴瘤(2 例)、原发性皮肤外周 T 细胞淋巴瘤未分类(2 例)、滤泡性蕈样真菌病(1 例)、Sézary 综合征(1 例)、皮肤γ-δ T 细胞淋巴瘤(1 例)、皮肤 CD8+侵袭性表皮细胞毒性 T 细胞淋巴瘤(1 例)和皮肤间变性大细胞淋巴瘤(1 例)。观察到男性居多,平均年龄为 74.1 岁。在所有患者中,CLL/SLL 先于第二种淋巴瘤的发生,大多数情况下(58%)为侵袭性。侵袭性细胞毒性 T 细胞淋巴瘤,通常是罕见的肿瘤,相对常见(30%)。
CLL/SLL 患者可能会在皮肤中发展第二种淋巴瘤,并且可能具有侵袭性。在该患者群体中,不典型的皮肤淋巴样浸润不应被假定为代表继发性 CLL/SLL 受累,需要进行彻底的免疫组织化学分析。